New Study Finds NT-proBNP Levels Predict New Atrial Fibrillation (AF) Up To Sixteen Years in Advance
A new study reports that blood levels of a protein hormone called N-terminal pro-B-type natriuretic peptide (NT-proBNP) predicts new atrial fibrillation, regardless of other afib risk factors.
Those with the highest levels were four times as likely to develop afib as those with the lowest levels. In the study, elevated levels of NT-proBNP occurred as much as 16 years before the onset of atrial fibrillation. Tests for NT-proBNP are available today, but are mainly used for screening for heart failure and heart disease.
To learn more, read: Study Finds Major Predictor for Development of New Atrial Fibrillation (AF)
Add A New CommentWe value and respect the experiences of all of our HERWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.
Add A New CommentComments
There are no comments yet. Be the first to get the conversation started.